Intraocular neovascularization Intraocular neovascularization
Conditions
Interventions
Sponsors
Ohnaka Masayuki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, Patients with diseases in which intraocular neovascular vessels do not disappear or reappeared after conventional therapy such as retinal photocoagulation 2, Retinopathy of prematurity, regardless of treatment, is zone I disease, zone II disease with stage 2+ or 3+, and aggressive posterior retinopathy of prematurity in the international classification 3, From 2 weeks old to 12 years old 4, Written informed consent by parents
Exclusion criteria
Exclusion criteria: 1, Patients with infarct disease, heart failure with poor control, hypertension, renal failure, abnormal blood coagulation ability, gastrointestinal ulcer 2, Patients who need to take other treatment priorities due to poor general condition 3. Patients who judged that neonatal specialists, pediatricians or the researcher are inappropriate as research subjects 4. Patients participating in other studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of retinal detachment after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of cataract after treatment Timing of retinal photocoagulation after treatment | — |
Contacts
Public ContactMasayuki Ohnaka
Kansai Medical University
Outcome results
None listed